BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2017

View Archived Issues

Lakewood-Amedex advancing second bisphosphocin candidate

Read More

Sentien Biotechnologies closes series A financing to fund development of SBI-101

Read More

FDA grants orphan drug designation to valproic acid for DLBCL

Read More

ProMetic Life Sciences completes plasminogen BLA filing

Read More

ConverGene enters CRADA with NINDS

Read More

Promising preclinical data for novel first-in-class pan-FGFR antibody, MM-161

Read More

Finch Therapeutics, Takeda to jointly develop FIN-524 for IBD

Read More

Pivotal ZEUS trial of Zolyd in cUTI meets primary endpoint

Read More

Allergan reports data from proof-of-concept phase II trial of Botox in major depressive disorder

Read More

Ligand and Marinus enter new agreement for Captisol-enabled ganaxolone

Read More

Charles River Laboratories and Nimbus Therapeutics enter strategic partnership

Read More

FUJIFILM presents novel irreversible and potent FLT3 inhibitor for AML treatment

Read More

Battelle and Nanotherapeutics form alliance on medical countermeasures

Read More

Enumeral Biomedical enters MoU with ICAV to pursue infectious disease collaboration

Read More

Takeda enrolls more than 20,000 children and adolescents in phase III dengue vaccine trial

Read More

R-IMPP, a new small molecule anti-secretagogue of PCSK9 with a new mechanism of action

Read More

Galapagos doses first patient in EQUATOR study of filgotinib

Read More

Corbus Pharmaceuticals to begin phase III study of anabasum in systemic sclerosis

Read More

First-in-human results for GSK-2881078 in the treatment of muscle wasting

Read More

Marina Biotech provides corporate update

Read More

Suven Life Sciences presents muscarinic acetylcholine M1 receptor PAMs

Read More

Calitor Sciences patents JAK, FLT3 and ARK kinase inhibitors

Read More

Merck KGaA divulges IRAK inhibitors

Read More

Ohio State University and collaborator identify estrogen receptor beta agonists

Read More

Metacrine discovers farnesoid X-activated receptor agonists

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 21, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing